创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

鲁杨, 赵天铭, 池哲勖, 王迪. 肿瘤微环境中的免疫细胞代谢调控[J]. 药学进展, 2022, 46(8): 577-587. DOI: 10.20053/j.issn1001-5094.2022.08.003
引用本文: 鲁杨, 赵天铭, 池哲勖, 王迪. 肿瘤微环境中的免疫细胞代谢调控[J]. 药学进展, 2022, 46(8): 577-587. DOI: 10.20053/j.issn1001-5094.2022.08.003
LU Yang, ZHAO Tianming, CHI Zhexu, WANG Di. Regulation of Immune Cell Metabolism in Tumor Microenvironment[J]. Progress in Pharmaceutical Sciences, 2022, 46(8): 577-587. DOI: 10.20053/j.issn1001-5094.2022.08.003
Citation: LU Yang, ZHAO Tianming, CHI Zhexu, WANG Di. Regulation of Immune Cell Metabolism in Tumor Microenvironment[J]. Progress in Pharmaceutical Sciences, 2022, 46(8): 577-587. DOI: 10.20053/j.issn1001-5094.2022.08.003

肿瘤微环境中的免疫细胞代谢调控

Regulation of Immune Cell Metabolism in Tumor Microenvironment

  • 摘要: 肿瘤微环境由各类细胞和非细胞组分构成,其中免疫细胞在肿瘤发生发展的过程中扮演了关键的角色。与在正常组织中不同,肿瘤微环境中免疫细胞的代谢重编程导致了它们功能的转变——常表现出减弱的炎症反应或增强的抑制性功能,从而协助了肿瘤的免疫逃逸,对于此过程的深入理解有助于为临床抗肿瘤治疗提供新的思路。综述在抗肿瘤免疫中具有主要功能的巨噬细胞、自然杀伤细胞、T细胞和B细胞的代谢重编程及其在肿瘤发生发展中发挥的功能和特点,以期能够展现出肿瘤微环境中免疫代谢调控蓝图的一部分,并基于代谢角度对肿瘤免疫治疗提供新的思路。

     

    Abstract: The tumor microenvironment is composed of various cellular and non-cellular components, among which immune cells play a key role in the process of tumor genesis and progression. Unlike in normal tissue, metabolic reprogramming of immune cells in tumor microenvironment leads to a shift in their function — often showing a reduced inflammatory response or an enhanced inhibitory function that assists in tumor immune escape. A deeper understanding of this process will provide new ideas for clinical antitumor therapy. This article reviews the metabolic reprogramming of macrophages, natural killer cells, T cells and B cells which play a main role in the process of anti-tumor immunity and their functions and features during tumor genesis and progression, so as to show the tumor microenvironment in the immune regulatory blueprint, and provide new insight into the metabolism of tumor immunotherapy.

     

/

返回文章
返回